Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • UAL vs GSK✓SelectedUSD · GSKUAL vs GSK performance historyLatest closeAs of+1.33%11/16
Stock and ETF performance explorer

UAL vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+63.2%
GSK return
+108.8%
Excess return
-45.6%
Maximum drawdown
-79.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+1.3%-0.1%+1.4%+1.4%
7D-8.0%-1.3%-6.7%-7.5%
30D+15.3%+2.7%+12.5%+14.1%
3M-11.6%+2.7%-14.3%-12.7%
6M+19.3%+3.3%+16.0%+17.1%
YTD-0.9%+6.5%-7.4%-4.1%
1Y+16.6%+10.7%+5.9%+11.1%
3Y+182.0%+64.4%+117.6%+112.0%
5Y+125.1%+46.7%+78.4%+77.7%
All+63.2%+108.8%-45.6%+16.0%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling